NCT02465944View on ClinicalTrials.gov

A Pilot Study of FFP104 in Subjects With Crohn's Disease

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

December 31, 2017

Conditions
Crohn's Disease
Interventions
DRUG

FFP104

Three intravenous infusions of FFP104 over 15 days (d0, d7 and d14)

DRUG

Placebo

Three intravenous infusions of 0.9% Saline over 15 days (d0, d7 and d14)

Trial Locations (2)

3000

RECRUITING

Universitair Ziekenhuis Leuven, Leuven

3015CE

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Fast Forward Pharmaceuticals

INDUSTRY

NCT02465944 - A Pilot Study of FFP104 in Subjects With Crohn's Disease | Biotech Hunter | Biotech Hunter